Clinically the method as implemented would therefore return an 'Unknown' phenotype for these mutations. All three rifampicin-resistance conferring mutations, including the disputed mutation I491F, not only have positive values of ΔΔG but also lie above the clinical threshold derived from the ECOFF/ECV. These mutations are therefore correctly predicted to confer resistance to rifampicin.